Skip to content

+358 20 7446 800 

  • English
  • Suomi

Search

Show search form

Medfiles
  • Company
    • About us
    • History
    • Medfiles’ team leaders
    • Management team
  • Our Services
        • Human Medicines
          • Regulatory Affairs
            • CMC
            • New Marketing Authorisations
            • Marketing Authorisation Maintenance
            • Local Regulatory Affairs
          • Pharmacovigilance
            • PV System Set Up
            • Post-Authorisation
            • ICSR
            • QPPV
            • Medical Information
          • Clinical Trials
            • Clinical Trial Safety
        • Veterinary Medicines
          • Marketing Authorisation & PV Readiness
          • Regulatory Affairs
            • CMC
            • New Marketing Authorisations
            • Marketing Authorisation Maintenance
            • Local Regulatory Affairs
          • Pharmacovigilance
            • PV System Set Up
            • Post-Authorisation
            • Adverse Event Prosessing
            • QPPV
        • Medical Device & IVDS
          • Quality & Regulatory
            • QMS
            • Technical Documentation
            • Clinical and Performance Evaluations
            • Registrations
            • Post-Market Services
            • Labelling, Translations & Marketing Materials
          • Clinical Investigations and Performance Studies
          • Post-Authorisation & Clinical Vigilance
        • Drug-device combinations
          • Strategy and classification
          • Development, documentation and regulatory alignment
          • Clinical trials and investigations
          • CMC
          • Approvals and conformity
          • Safety & PMS
          • Lifecycle management
        • Food
          • Novel Foods
          • GRAS, NDI and FAP
          • Health Claims
          • Food and Food Supplement Labelling and Marketing Materials
          • FSGs and FSMPs
          • Regulatory Positioning and Strategies
          • Clinical Studies
        • Feed
          • Regulatory Positioning and Strategies
          • Feed Material and Additive Registrations
          • GRAS and FAP
          • Labelling and Marketing Materials
          • Feed for Particular Nutritional Purposes
  • Insights
  • Careers
  • Contact us
    • Contact form
    • Contact our units
    • Offices
    • Invoicing

Product: Animal feed

  • Meet Medfiles experts at EuroTier 2026

    21.09.2026

    Medfiles at EuroTier 2026
  • The proposed FDA GRAS rule is out for a 120-day comment period: what will change if the rule is adopted

    17.08.2026

    proposed FDA GRAS rule
  • Preparing a PARNUT application in the EU: what EFSA’s new guidance will mean for companies

    30.07.2026

  • 3 trends affecting the animal health industry in 2026

    14.04.2026

    3 trends affecting the animal health industry in 2026
  • UK-EU SPS Agreement: What could alignment with EU rules mean for GB market authorisations of food and feed products

    13.03.2026

    UK–EU SPS Agreement
  • European Biotech Act: what it means for EU food and feed regulation

    10.02.2026

    European Biotech Act
  • Food and feed ingredients and additives in the United States: is the self-affirmed GRAS pathway coming to an end

    29.01.2026

    self-affirmed GRAS
  • What’s on the horizon for feed additives regulatory affairs in the EU and UK

    29.01.2026

    feed additives regulatory affairs in the EU and UK
  • Funding opportunities for food and feed innovation: key programmes, requirements and considerations for applicants

    13.11.2025

    food and feed innovation funding
1 2 3 Next
Medfiles - Securing a healthier tomorrow

© 2026 Copyright Medfiles.
All rights reserved.

Privacy Policy
Notification Channel

WDB Group

Services

Human medicine
Veterinary medicine
Medical Device & IVD
Drug-device combinations
Food
Feed

Contact

Rajatorpantie 41 C, FI-01640 Vantaa, Finland
VAT: FI10475691

+358 20 7446 800

Contact form
Subscribe to our Newsletter

© 2026 Medfiles • Built with GeneratePress